托法替布
Tofacitinib.
作者信息
Cada Dennis J, Demaris Kendra, Levien Terri L, Baker Danial E
机构信息
Executive Editor, The Formulary ;
Clinical Instructor, Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington;
出版信息
Hosp Pharm. 2013 May;48(5):413-24. doi: 10.1310/hpj4805-413.
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, call The Formulary at 800-322-4349. The May 2013 monograph topics are ado-trastuzumab emtansine, pomalidomide, mipomersen, pasireotide diaspartate, and glycerol phenylbutyrate. The DUE/MUE is on atypical antipsychotics, extended release.
每月，《处方集专论服务》的订阅者会收到5至6篇关于新发布或处于3期临床试验后期的药物的详细专论。这些专论面向药学与治疗学委员会。订阅者还会每月收到1页关于对议程以及药房/护理在职培训有用的药物的简要专论。每月还会提供一份全面的目标药物利用评估/用药使用评估（DUE/MUE）。订阅后，专论会以印刷品形式发送，也可在线获取。专论可根据机构需求进行定制。现在每月会随《处方集专论服务》发布一次药物类别综述。通过《处方集》的合作，《医院药学》会在本专栏发表精选综述。有关《处方集专论服务》的更多信息，请致电《处方集》800 - 322 - 4349。2013年5月的专论主题是ado曲妥珠单抗恩美曲妥珠单抗、泊马度胺、米泊美生、帕西瑞肽天冬氨酸盐和甘油苯丁酯。DUE/MUE是关于非典型抗精神病药物长效制剂的。
Zotero 插件